Tuberculosis, before and after Antiretroviral Therapy among HIV-Infected Children in Nigeria: What Are the Risk Factors?
- PMID: 27232185
- PMCID: PMC4883775
- DOI: 10.1371/journal.pone.0156177
Tuberculosis, before and after Antiretroviral Therapy among HIV-Infected Children in Nigeria: What Are the Risk Factors?
Abstract
Introduction: In Nigeria, there is a dearth of pediatric data on the risk factors associated with tuberculosis (TB), before and after antiretroviral therapy (ART).
Methodology: A retrospective observational cohort study, between October 2010 and December 2013, at the Federal Medical Centre, Makurdi, Nigeria. TB was noted among children less than 15 years of age at ART enrolment (prevalent TB-PrevTB), within 6 months (early incident tuberculosis-EITB) and after 6 months (late incident tuberculosis-LITB) of a 12-month follow-up on ART. Potential risk factors for PrevTB and incident TB were assessed using the multivariate logistic and Cox regression models respectively.
Results: Among 368 HIV-1 infected children, PrevTB was diagnosed in 73 children (19.8%). Twenty-eight EITB cases were diagnosed among 278 children over 132 person-years (py) with an EITB rate of 21.2/100 py. Twelve LITB cases were seen among 224 children over 221.9 py with a LITB rate of 5.4/100 py. A significant reduction in the incidence rates of TB was found over time (75%, p˂ 0.001). Young age of children (12-35 months, aOR; 24, 95% CI; 4.1-146.6, p ˂ 0.001; 36-59 months, aOR;21, 95%CI;4.0-114.3, p ˂ 0.001); history of TB in children (aOR; 29, 95% CI; 7.3-119.4, P˂ 0.001); severe immunosuppression (aOR;38, 95% CI;12-123.2,p ˂ 0.001); oropharyngeal candidiasis (aOR;3.3, 95% CI; 1.4-8.0, p = 0.009) and sepsis (aOR; 3.2, 95% CI;1.0-9.6, p = 0.043) increased the risk of PrevTB. Urban residency was protective against EITB (aHR; 0.1, 95% CI; 0.0-0.4, p = 0.001). Virological failure (aHR; 4.7, 95% CI; 1.3-16.5, p ˂ 0.001) and sepsis (aHR; 26, 95% CI; 5.3-131.9, p ˂ 0.001) increased the risk of LITB.
Conclusions: In our cohort of HIV-infected children, a significant reduction in cases of incident TB was seen following a 12-month use of ART. After ART initiation, TB screening should be optimized among children of rural residency, children with sepsis, and those with poor virological response to ART.
Conflict of interest statement
Figures

Similar articles
-
The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.Pediatr Infect Dis J. 2009 Jul;28(7):626-32. doi: 10.1097/INF.0b013e31819665c5. Pediatr Infect Dis J. 2009. PMID: 19451858
-
Impact of expanded antiretroviral use on incidence and prevalence of tuberculosis in children with HIV in Kenya.Int J Tuberc Lung Dis. 2013 Oct;17(10):1291-7. doi: 10.5588/ijtld.12.0740. Int J Tuberc Lung Dis. 2013. PMID: 24025380 Free PMC article.
-
Severe manifestations of extrapulmonary tuberculosis in HIV-infected children initiating antiretroviral therapy before 2 years of age.Arch Dis Child. 2014 Nov;99(11):998-1003. doi: 10.1136/archdischild-2013-305509. Epub 2014 Jun 17. Arch Dis Child. 2014. PMID: 24938535
-
Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.Int J Infect Dis. 2017 Mar;56:39-44. doi: 10.1016/j.ijid.2017.01.023. Epub 2017 Feb 1. Int J Infect Dis. 2017. PMID: 28161460 Review.
-
HIV-Associated Tuberculosis in Children and Adolescents: Evolving Epidemiology, Screening, Prevention and Management Strategies.Pathogens. 2021 Dec 29;11(1):33. doi: 10.3390/pathogens11010033. Pathogens. 2021. PMID: 35055981 Free PMC article. Review.
Cited by
-
How Far Does Highly Active Antiretroviral Treatment Reduce TB Incidence among Children? A Marginal Structural Modeling Analysis, Southwest Ethiopia.Ethiop J Health Sci. 2020 Sep;30(5):653-660. doi: 10.4314/ejhs.v30i5.3. Ethiop J Health Sci. 2020. PMID: 33911825 Free PMC article.
-
Effectiveness of a community-based intervention (Konga model) to address the factors contributing to viral load suppression among children living with HIV in Tanzania: a cluster-randomized clinical trial protocol.Biol Methods Protoc. 2022 Jan 7;7(1):bpac002. doi: 10.1093/biomethods/bpac002. eCollection 2022. Biol Methods Protoc. 2022. PMID: 35155815 Free PMC article.
-
The burden of vaccine-preventable diseases among HIV-infected and HIV-exposed children in sub-Saharan Africa: a systematic review and meta-analysis.Hum Vaccin Immunother. 2019;15(11):2590-2605. doi: 10.1080/21645515.2019.1599676. Epub 2019 May 22. Hum Vaccin Immunother. 2019. PMID: 30945963 Free PMC article.
-
Isolation and Immunological Detection of Mycobacterium Tuberculosis from HIV and Non-HIV Patients in Benue State, Nigeria.Ethiop J Health Sci. 2020 Jan;30(1):55-64. doi: 10.4314/ejhs.v30i1.8. Ethiop J Health Sci. 2020. PMID: 32116433 Free PMC article.
-
Host Immunity to Mycobacterium tuberculosis Infection Is Similar in Simian Immunodeficiency Virus (SIV)-Infected, Antiretroviral Therapy-Treated and SIV-Naïve Juvenile Macaques.Infect Immun. 2023 May 16;91(5):e0055822. doi: 10.1128/iai.00558-22. Epub 2023 Apr 11. Infect Immun. 2023. PMID: 37039653 Free PMC article.
References
-
- World Health Organization. Global tuberculosis report. 2013. Available: http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf. Accessed 15 December 2014.
-
- Joint United Nations Programme on HIV/AIDS. 2013 progress report on the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. Available: http:// http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/.... Accessed 15 December 2014.
-
- Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis. 2004; 8(5):636–47. - PubMed
-
- Graham SM, Coulter JB, Gilks CF. Pulmonary disease in HIV-infected African children. Int J Tuberc Lung Dis. 2001; 5(1):12–23. - PubMed
-
- Coovadia HM, Jeena P, Wilkinson D. Childhood human immunodeficiency virus and tuberculosis co-infections: reconciling conflicting data. Int J Tuberc Lung Dis. 1998; 2 (10):844–51. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical